This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fikrig, E Articles by Flavell, R A Search for Related Content PubMed PubMed Citation Articles by Fikrig, E Articles by Flavell, R A

 Previous Article  |  Next Article 

Infect Immun. 1992 March; 60(3): 773-777

Long-term protection of mice from Lyme disease by vaccination with OspA.

Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06510.

ABSTRACT

Mice vaccinated with recombinant outer surface protein A (OspA) have been shown to be protected from infection with Borrelia burgdorferi, the agent of Lyme disease, when sacrificed 14 days after challenge with an intradermal inoculum of the spirochete. To determine whether infection was not merely delayed and that protection was long-lasting, we sacrificed vaccinated mice 60, 120, and 180 days after challenge; and to determine whether vaccinated mice retained their immune state over long periods, we challenged mice with B. burgdorferi 60, 90, 120, and 150 days after vaccination. The results of both groups of experiments show that the mice remained free from infection and disease and extend the usefulness of OspA as a vaccine candidate for Lyme borreliosis.

This article has been cited by other articles:

• del Rio, B., Dattwyler, R. J., Aroso, M., Neves, V., Meirelles, L., Seegers, J. F. M. L., Gomes-Solecki, M. (2008). Oral Immunization with Recombinant Lactobacillus plantarum Induces a Protective Immune Response in Mice with Lyme Disease. CVI 15: 1429-1435 [Abstract] [Full Text]  
• Nardelli, D. T., Callister, S. M., Schell, R. F. (2008). Lyme Arthritis: Current Concepts and a Change in Paradigm. CVI 15: 21-34 [Full Text]  
• Munson, E. L., Nardelli, D. T., Luk, K. H. K., Remington, M. C., Callister, S. M., Schell, R. F. (2006). Interleukin-6 Promotes Anti-OspA Borreliacidal Antibody Production In Vitro. CVI 13: 19-25 [Abstract] [Full Text]  
• Holden, K., Hodzic, E., Feng, S., Freet, K. J., Lefebvre, R. B., Barthold, S. W. (2005). Coinfection with Anaplasma phagocytophilum Alters Borrelia burgdorferi Population Distribution in C3H/HeN Mice. Infect. Immun. 73: 3440-3444 [Abstract] [Full Text]  
• Munson, E. L., DeCoster, D. J., Nardelli, D. T., England, D. M., Callister, S. M., Schell, R. F. (2004). Neutralization of Gamma Interferon Augments Borreliacidal Antibody Production and Severe Destructive Lyme Arthritis in C3H/HeJ Mice. CVI 11: 35-41 [Abstract] [Full Text]  
• Thomas, V., Anguita, J., Barthold, S. W., Fikrig, E. (2001). Coinfection with Borrelia burgdorferi and the Agent of Human Granulocytic Ehrlichiosis Alters Murine Immune Responses, Pathogen Burden, and Severity of Lyme Arthritis. Infect. Immun. 69: 3359-3371 [Abstract] [Full Text]  
• Shang, E. S., Champion, C. I., Wu, X.-Y., Skare, J. T., Blanco, D. R., Miller, J. N., Lovett, M. A. (2000). Comparison of Protection in Rabbits against Host-Adapted and Cultivated Borrelia burgdorferi following Infection-Derived Immunity or Immunization with Outer Membrane Vesicles or Outer Surface Protein A. Infect. Immun. 68: 4189-4199 [Abstract] [Full Text]  
• Thanassi, W. T., Schoen, R. T. (2000). The Lyme Disease Vaccine: Conception, Development, and Implementation. ANN INTERN MED 132: 661-668 [Abstract] [Full Text]  
• Anguita, J., Samanta, S., Revilla, B., Suk, K., Das, S., Barthold, S. W., Fikrig, E. (2000). Borrelia burgdorferi Gene Expression In Vivo and Spirochete Pathogenicity. Infect. Immun. 68: 1222-1230 [Abstract] [Full Text]  
• Barthold, S. W. (1999). Specificity of Infection-Induced Immunity among Borrelia burgdorferi Sensu Lato Species. Infect. Immun. 67: 36-42 [Abstract] [Full Text]  
• Sigal, L. H., Zahradnik, J. M., Lavin, P., Patella, S. J., Bryant, G., Haselby, R., Hilton, E., Kunkel, M., Adler-Klein, D., Doherty, T., Evans, J., Malawista, S. E., Molloy, P. J., Seidner, A. L., Sabetta, J. R., Simon, H. J., Klempner, M. S., Mays, J., Marks, D. (1998). A Vaccine Consisting of Recombinant Borrelia burgdorferi Outer-Surface Protein A to Prevent Lyme Disease. NEJM 339: 216-222 [Abstract] [Full Text]